| Trial ID: | L0103 |
| Source ID: | NCT01377285
|
| Associated Drug: |
Arb
|
| Title: |
Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
|
| Acronym: |
CKD
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Renal Failure
|
| Interventions: |
DRUG: ARB|DRUG: Pentoxifylline|DRUG: Placebo (for Pentoxifylline)
|
| Outcome Measures: |
Primary: doubling of serum creatinine, ESRD, and death from any cause, 3 years | Secondary: changes of microalbuminuria or proteinuria, and development of heart failure, nonfatal myocardial infarction, and stroke or transient ischemic attack., 3 years
|
| Sponsor/Collaborators: |
Sponsor: National Taiwan University Hospital | Collaborators: Far Eastern Memorial Hospital|Mackay Memorial Hospital|Taipei Medical University Hospital|Shin Kong Wu Ho-Su Memorial Hospital|Cathay General Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
350
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-06
|
| Completion Date: |
2018-12
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-14
|
| Locations: |
National Taiwan University Hospital, Taipei, 100, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT01377285
|
